Format

Send to

Choose Destination
Oncotarget. 2016 May 10;7(19):27641-54. doi: 10.18632/oncotarget.8505.

Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin.

Author information

1
Joint Biobank, Office of Human Research, Taipei Medical University, Taipei, Taiwan.
2
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
3
PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
4
Biomedical Imaging Research Center, National Yang-Ming University, Taipei, Taiwan.
5
Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York, USA.
6
Stem Cell Research Center, National Yang-Ming University, Taipei, Taiwan.
7
Department of Periodontology, School of Dentistry, National Defense Medical College, Taipei, Taiwan.
8
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, New York, USA.
9
Department of Medicine, Albany Medical College, Albany, New York, USA.
10
Department of Biochemistry and Molecular Cell Biology, College of Medicine, Taipei Medical University, Taipei, Taiwan.
11
Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Abstract

Obesity results in increased secretion of cytokines from adipose tissue and is a risk factor for various cancers. Leptin is largely produced by adipose tissue and cancer cells. It induces cell proliferation and may serve to induce various cancers. OB3-leptin peptide (OB3) is a new class of functional leptin peptide. However, its mitogenic effect has not been determined. In the present study, because of a close link between leptin and the hypothalamic-pituitary-thyroid axis, OB3 was compared with leptin in different thyroid cancer cells for gene expression, proliferation and invasion. Neither agent stimulated cell proliferation. Leptin stimulated cell invasion, but reduced adhesion in anaplastic thyroid cancer cells. Activated ERK1/2 and STAT3 contributed to leptin-induced invasion. In contrast, OB3 did not affect expression of genes involved in proliferation and invasion. In vivo studies in the mouse showed that leptin, but not OB3, significantly increased circulating levels of thyrotropin (TSH), a growth factor for thyroid cancer. In summary, OB3 is a derivative of leptin that importantly lacks the mitogenic effects of leptin on thyroid cancer cells.

KEYWORDS:

OB3-leptin peptide; cancer cell invasion; leptin; obesity

PMID:
27050378
PMCID:
PMC5053677
DOI:
10.18632/oncotarget.8505
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center